Navigation Links
AGI Dermatics President to be Keynote Speaker at the 11th Annual Sunscreen Symposium
Date:9/7/2007

ORLANDO, Fla., Sept. 7 /PRNewswire/ -- Daniel B. Yarosh, PhD, President and CEO AGI Dermatics, will deliver the keynote presentation at the 11th Annual Sunscreen Symposium today in Lake Buena Vista, FL. The multi-day gathering (September 6th-9th) of cosmetic chemists is sponsored by the Florida chapter of the Society of Cosmetic Chemists. Dr. Yarosh will present "Beyond Sunscreens: DNA Repair and Photoaging" to the more than 250 cosmetic chemists from around the U.S. and throughout the world who are scheduled to attend.

"Photoaging in skin is an extremely complex process and the genomic revolution has given us tools to understand UV-induced damage at the cellular level," said Dr. Yarosh. "Events such as the Sunscreen Symposium provide a forum in which we can share knowledge and ideas with colleagues, and further the sunscreen advancements around the world."

Dr. Yarosh, widely recognized as a pioneer in the science of DNA repair, is the author of more than 100 scientific papers and two dozen patents. He is an active participant in international photobiology societies and the New York biotechnology community.

AGI Dermatics founded by Dr. Yarosh in 1985, has emerged as a world leader in DNA repair technology for skin and is best known for developing Dimericine(R) (T4N5), a drug in testing for treating patients with skin cancers and pre-cancers. The U.S. Food & Drug Administration recently granted Fast Track designation for Dimericine for treatment of solar and ultraviolet photosensitivity in patients with Xeroderma Pigmentosum (XP), a rare genetic disorder that blocks the body's natural ability to repair DNA damage caused by ultraviolet light.

AGI Dermatics is also the developer of Remergent, a doctor-dispensed skincare line based on the science of DNA repair.

AGI Dermatics is the bio-pharmaceutical laboratory that has led the research of DNA repair of the skin for more than 20 years. Founded by Daniel B. Yarosh, PhD, AGI Dermatics specializes in skin photobiology, dedicating research and development to DNA repair, solar impact on the immune system, and cell-signaling in skin. The company's application of groundbreaking active ingredients and meticulously engineered liposome delivery systems is validated in controlled clinical studies and published in dozens of peer-reviewed scientific and medical journals. http://www.agiderm.com


'/>"/>
SOURCE AGI Dermatics
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Siemens health services president calls IT benefits unassailable
2. Wisconsin IT association names Gee president, CEO
3. Merge Healthcare promotes Bowers to president
4. Quintessence Biosciences names new president
5. VanderSanden appointed president of AT&T Wisconsin
6. Merge president steps down in wake of shareholder suits
7. Milwaukees PointOne appoints new president and CEO
8. Cars.com president slated for Milwaukee event
9. Sonic Foundry names new senior vice president
10. MyWeather names new president, marketing officer
11. At Berbee, president replaces founder as CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... -- Research and Markets has announced the addition of ... Application - Global Opportunity Analysis and Industry Forecast, 2014-2022" report ... ... projected to reach $15,737 million by 2022 from $6,521 in 2015, ... Omic technologies segment accounted for more than half of ...
(Date:1/19/2017)... Research and Markets ... announced the addition of the "Implantable Biomaterials Market ... report to their offering. Report Highlights: ... analysis on current and future market trends to identify the investment opportunities ... the base numbers Key market trends across the business ...
(Date:1/19/2017)... , Jan. 19, 2017  ArmaGen, Inc., ... Schmidt , Ph.D., as chief executive officer, as ... directors. Dr. Schmidt brings to ArmaGen more than 17 ... research and development of biotherapeutics and pharmaceuticals. ... with the diverse experience and skillset necessary to ...
(Date:1/19/2017)... Island, NY (PRWEB) , ... January 19, 2017 , ... ... at an exponential rate. The tremendous growth is accounted to two main factors. ... the table and the expanding network of vendors supplying FireflySci products all around the ...
Breaking Biology Technology:
(Date:12/8/2016)... ALAMEDA, Calif. , Dec. 8, 2016  Singulex, ... Single Molecule Counting technology, entered into a license and ... in serving science. The agreement provides Singulex access to ... Europe is used to diagnose ... the United States to aid in assessing ...
(Date:12/7/2016)... , December 7, 2016 BioCatch , ... expansion of its patent portfolio, which grew to over 40 granted and ... , , ... recently filed patent entitled " System, Device, and Method Estimating ... that enables device makers to forego costly hardware components needed to estimate ...
(Date:12/7/2016)... --  Veridium , a leader in biometrics-based authentication ... James Stickland . Stickland, a seasoned financial ... served in senior executive roles for HSBC, JPMorgan ... a pipeline of venture capital and accelerating innovation ... as managing director of U.K.-based fintech firm Red ...
Breaking Biology News(10 mins):